Pharmacy Technician Certification Exams — Certified Pharmacy Technician Certification
Answer: D
A pharmacy that discovers the theft of a controlled substance must notify the Drug Enforcement Administration.
When a pharmacy discovers the theft of a controlled substance, it is required by federal regulations to notify the Drug Enforcement Administration (DEA). This is a critical step in ensuring compliance with legal standards regarding the handling of controlled substances.
A) local law enforcement
While notifying local law enforcement may be advisable in cases of theft, it is not a federal requirement specified in the regulations concerning controlled substances. The primary responsibility lies with the DEA in this context.
B) the State Board of Pharmacy
The State Board of Pharmacy may need to be informed in certain situations, but federal regulations specifically mandate that the DEA be notified first. Thus, this option does not align with the immediate federal requirements.
C) the Food and Drug Administration
The Food and Drug Administration (FDA) does not oversee the theft reporting of controlled substances. Its role is primarily focused on drug safety and efficacy, making this option incorrect concerning the reporting obligation for theft.
D) the Drug Enforcement Administration
The Drug Enforcement Administration (DEA) is the correct entity to notify when a pharmacy discovers the theft of a controlled substance. Federal regulations explicitly state that this notification is essential to maintain accountability and regulatory compliance.
Conclusion
The requirement to notify the Drug Enforcement Administration (DEA) is clearly outlined in federal regulations concerning the theft of controlled substances, making option D the definitive correct answer. Other options, while relevant in broader contexts, do not fulfill the specific federal obligation required in this scenario. Thus, understanding the correct reporting channels is crucial for legal compliance in pharmacy operations.
Answer: C
Nitroglycerin sublingual tablets should be dispensed and stored in the manufacturer's original container.
Nitroglycerin sublingual tablets are sensitive to moisture and light, which can degrade their effectiveness. Therefore, it is essential to keep them in their original container to maintain their potency and ensure patient safety.
A) Duloxetine delayed-release capsules
Duloxetine delayed-release capsules do not have the same sensitivity to environmental factors as nitroglycerin. They can generally be stored in standard containers without a significant risk of degradation.
B) Calcium carbonate chewable tablets
Calcium carbonate chewable tablets are stable and do not require storage in their original container to maintain their effectiveness. They can be stored in various types of containers without compromising their quality.
C) Nitroglycerin sublingual tablets
Nitroglycerin sublingual tablets must be stored in the manufacturer’s original container to protect them from light and moisture. This is crucial for preserving their efficacy and preventing potential health risks associated with degraded medication.
D) Hyoscyamine oral disintegrating tablets
Hyoscyamine oral disintegrating tablets do not have specific storage requirements that necessitate them being kept in the original container. They can be adequately stored in other suitable containers without affecting their stability.
Conclusion
The requirement for nitroglycerin sublingual tablets to be dispensed and stored in the manufacturer’s original container is critical due to their sensitivity to light and moisture, which can affect their potency. Other options, while still important medications, do not have the same stringent storage requirements, making them less critical in this context. Thus, nitroglycerin stands out as the correct answer.
3. According to federal law,a valid prescription for eszopiclone must include the:
Answer: A
A valid prescription for eszopiclone must include the patient's address.
A valid prescription for eszopiclone requires the patient's address to ensure proper identification and record-keeping as mandated by federal regulations.
A) Patient's address
This option is correct as federal law necessitates that a valid prescription includes the patient's address to accurately identify the patient and maintain proper documentation for controlled substances.
B) Pharmacy's DEA number
While the pharmacy's DEA number is important for the dispensing of controlled substances, it is not a required element on the prescription itself. Therefore, this option is incorrect.
C) Patient's insurance information
Patient's insurance information is not a requirement on a prescription for eszopiclone. This information may be collected for billing purposes but does not constitute a necessary component of a valid prescription, making this option incorrect.
D) Prescriber's phone number
Although it can be beneficial to include the prescriber's phone number for clarifications or follow-ups, it is not mandated by federal law as a necessary element of a valid prescription. Thus, this option is also incorrect.
Conclusion
The requirement for a patient's address in a valid prescription ensures compliance with federal regulations regarding controlled substances. Other options, while relevant in the context of prescription management, do not fulfill the legal criteria for a valid prescription, thereby confirming that option A is the only correct choice.
4. Efavirenz is considered a high-alert medication in a community pharmacy setting because it is an:
Answer: D
Efavirenz is considered a high-alert medication in a community pharmacy setting because it is an antiretroviral.
Efavirenz is categorized as an antiretroviral medication, specifically utilized in the treatment of HIV. This classification underscores its potential risks and the necessity for careful management in a community pharmacy setting.
A) anticoagulant
Anticoagulants are medications that prevent blood clotting, such as warfarin or heparin. Efavirenz does not function in this capacity, making this option incorrect regarding its classification and the associated risks in a pharmacy setting.
B) opioid
Opioids are a class of drugs typically used for pain management, such as morphine or oxycodone. Efavirenz is not an opioid; thus, this option does not accurately represent its role or the reason it is considered a high-alert medication.
C) insulin
Insulin is a hormone used for managing diabetes by regulating blood sugar levels. While insulin is also a high-alert medication, efavirenz is unrelated to this category and serves a different therapeutic purpose, which makes this option incorrect.
D) antiretroviral
Efavirenz is an antiretroviral medication used in the treatment of HIV, which places it in a category of medications that require heightened attention due to their complexity and potential for serious side effects. This classification justifies its status as a high-alert medication in pharmacies.
Conclusion
Efavirenz is correctly identified as an antiretroviral medication, which is crucial for the treatment of HIV. Its classification highlights the importance of monitoring and managing its use due to the serious implications associated with antiretroviral therapy. The other options fail to capture the nature of efavirenz, confirming that D is the only appropriate choice.
Answer: B
Medication reconciliation detects a patient on two medications in the same therapeutic classification.
Medication reconciliation is a systematic process used to ensure that a patient's medication lists are accurate and consistent, particularly when they are on multiple medications within the same therapeutic classification. This function helps identify potential duplications and overlaps in therapy, ensuring patient safety.
A) Drug-allergy interaction
Drug-allergy interaction monitoring focuses on identifying potential allergic reactions a patient may have to specific medications based on their allergy history. While important for patient safety, it does not specifically address the issue of patients taking multiple medications within the same therapeutic classification.
B) Medication reconciliation
Medication reconciliation is the correct answer as it involves reviewing and verifying a patient's medication orders to prevent duplication of therapies within the same classification. This process is critical for maintaining safe and effective medication management.
C) Drug-lab test interaction
Drug-lab test interaction monitoring assesses whether specific medications may interfere with laboratory test results. While it is a valuable function, it does not pertain to identifying multiple medications within the same therapeutic classification.
D) IV compatibility
IV compatibility focuses on ensuring that intravenous medications can be safely administered together without adverse reactions. This function is specific to intravenous therapy and does not address the broader issue of a patient taking multiple medications in the same therapeutic classification.
Conclusion
Medication reconciliation is essential for identifying patients on multiple medications in the same therapeutic classification, preventing potential medication errors and enhancing patient safety. All other options do not specifically address this critical aspect of medication management, thereby confirming that B is the only correct choice.
6. What do the last two digits of a National Drug Code (NDC) number identify?
Answer: B
The last two digits of a National Drug Code (NDC) number identify the trade package size.
The last two digits of an NDC number specifically denote the trade package size, which indicates the quantity or volume of the drug product contained within the packaging.
A) Specific drug product
This option is incorrect because the specific drug product is identified by the first four digits of the NDC, which represent the unique identifier for the drug itself. The last two digits do not convey information about the product's formulation or identity.
B) Trade package size
This option is correct as the last two digits of the NDC are designated to identify the trade package size. This provides essential information regarding the amount of drug contained in each package, which is crucial for dispensing and inventory purposes.
C) Labeler or manufacturer
This option is incorrect because the labeler or manufacturer is represented by the middle portion of the NDC, which consists of the next four digits. The last two digits do not indicate the entity responsible for producing the drug.
D) Drug schedule
This option is not correct since the drug schedule, which categorizes drugs based on their potential for abuse and medical use, is not represented within the NDC. The NDC does not include any information about the scheduling of a drug.
Conclusion
The correct answer is that the last two digits of the NDC identify the trade package size, a critical detail for understanding how much of the drug is provided in each package. Other options do not accurately reflect the information conveyed by the last two digits, thereby confirming their incorrectness. The structure of the NDC is specifically designed to streamline identification and classification, with each segment serving a distinct purpose.
Answer: B
B) ISMP
ISMP, or the Institute for Safe Medication Practices, is a non-profit organization dedicated to promoting safe medication use and preventing medication errors through education and research for healthcare providers and consumers.
A) FDA
The FDA, or Food and Drug Administration, is a governmental agency responsible for regulating food and drug safety. While it plays a role in medication safety, it is not primarily focused on educating healthcare providers and consumers about preventing medication errors, which makes it an incorrect choice in this context.
B) ISMP
ISMP is specifically designed to educate healthcare providers and consumers about medication safety. Its mission directly aligns with the goal of preventing medication errors, making it the correct answer.
C) DEA
The DEA, or Drug Enforcement Administration, is focused on enforcing controlled substances laws and regulations. Its primary role is not education aimed at preventing medication errors, which is why this option is incorrect.
D) CDC
The CDC, or Centers for Disease Control and Prevention, is primarily concerned with public health and disease prevention. While it may address medication-related issues, its main focus does not include the specific education about preventing medication errors like that of ISMP, making this option incorrect.
Conclusion
ISMP stands out as the only organization specifically focused on educating healthcare providers and consumers to prevent medication errors, fulfilling the requirements of the question. The other options, while important in their respective roles, do not primarily address the educational aspect of medication safety. Thus, B is the definitive correct choice.
Answer: A
Safety Data Sheets (SDS) contain information about the proper protection required for handling specific agents contained in the pharmacy.
Safety Data Sheets (SDS) are essential documents that provide detailed information on the hazards of chemical substances and the necessary protective measures to safely handle them.
A) Safety Data Sheets (SDS)
Safety Data Sheets (SDS) are specifically designed to convey information about the properties of chemicals, including safety measures, handling instructions, and personal protective equipment required. They are crucial for ensuring safety in environments where hazardous materials are present, making them the correct reference for this question.
B) Orange Book
The Orange Book, officially known as the Approved Drug Products with Therapeutic Equivalence Evaluations, primarily focuses on drug approval and bioequivalence rather than safety guidelines or protective measures for handling agents. Therefore, it does not provide the necessary information about proper protection for handling specific agents.
C) Lexicomp
Lexicomp is a comprehensive drug database that provides information on drug interactions, dosing, and pharmacology. While it contains valuable information for pharmacists, it does not specifically focus on the protective measures required for handling hazardous agents, making it an unsuitable reference for this particular question.
D) American Drug Index (ADI)
The American Drug Index (ADI) serves as a reference for drug identification and provides basic information about various medications. However, it does not contain detailed safety information or guidelines on the protection required when handling specific agents, rendering it irrelevant for this question.
Conclusion
Safety Data Sheets (SDS) are the definitive source for information on the proper protection required for handling specific agents in a pharmacy setting. In contrast, the other options—Orange Book, Lexicomp, and American Drug Index—do not provide the necessary safety details, making them inadequate references for this inquiry. Thus, SDS is the only correct choice.
9. Prior to dispensing, it would be most appropriate to store Humira:
Answer: B
Humira should be stored in a refrigerator, at 2°C to 8°C (36°F to 46°F).
Storing Humira in a refrigerator at the recommended temperature range of 2°C to 8°C ensures the medication remains stable and effective prior to dispensing.
A) in a freezer, at -20°C to -10°C (-4°F to 14°F)
Storing Humira in a freezer is incorrect because freezing can damage the medication, rendering it ineffective. The recommended storage conditions specifically exclude freezing temperatures.
B) in a refrigerator, at 2°C to 8°C (36°F to 46°F)
This option is correct as it aligns with the manufacturer's guidelines for storing Humira. Keeping the medication in this temperature range preserves its stability and efficacy.
C) cool, at 8°C to 15°C (46°F to 59°F)
While this option suggests a cool storage environment, it exceeds the upper limit for optimal storage of Humira. Storing it at temperatures above 8°C risks compromising the drug's integrity.
D) at room temperature, at 15°C to 30°C (59°F to 86°F)
Storing Humira at room temperature is not appropriate, as it falls outside the recommended temperature range. This could lead to degradation of the medication and loss of effectiveness.
Conclusion
The correct answer, storing Humira in a refrigerator at 2°C to 8°C, is crucial for maintaining its stability and efficacy. All other options fail to meet the required storage conditions, either by suggesting inappropriate temperatures or by risking the medication's integrity. Proper storage is essential for ensuring the effectiveness of Humira when it is needed for treatment.
Answer: C
Multiple sclerosis is an autoimmune disorder that causes muscle weakness, numbness or tingling, and loss of coordination.
Multiple sclerosis is characterized by the immune system attacking the protective covering of nerves, leading to symptoms such as muscle weakness, numbness, tingling, and coordination issues.
A) Reyes syndrome
Reyes syndrome is a rare but serious condition that causes swelling in the liver and brain, primarily affecting children and adolescents recovering from a viral infection. It is not an autoimmune disorder and does not present with muscle weakness, numbness, or coordination loss, making it an incorrect choice.
B) Polyneuropathy
Polyneuropathy refers to a group of disorders that result from damage to the peripheral nerves, often causing weakness, numbness, and pain, typically in the hands and feet. While it can involve similar symptoms, it is not classified as an autoimmune disorder, thus it does not fit the description provided in the question.
C) Multiple sclerosis
Multiple sclerosis is indeed an autoimmune disorder where the immune system attacks the myelin sheath of neurons, leading to various neurological symptoms, including muscle weakness, numbness, tingling, and loss of coordination. This option directly aligns with the characteristics described in the question.
D) Alzheimers disease
Alzheimer's disease is a progressive neurodegenerative disorder primarily affecting memory and cognitive functions. It is not classified as an autoimmune disorder and does not typically present with symptoms of muscle weakness, numbness, or loss of coordination, making it an incorrect option.
Conclusion
Multiple sclerosis is the only option that fits the criteria of being an autoimmune disorder that leads to muscle weakness, numbness, and coordination issues. The other options either do not meet the autoimmune classification or do not present the specific symptoms described, thereby confirming that multiple sclerosis is the correct answer.